Certified by Founder
Lodge
Avenue Therapeutics
start up
United States
- New York, NY
- 13/12/2021
- Unknown
- $2,000,000
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company.
Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
- Industry Biotechnology Research
- Website https://www.avenuetx.com/
- LinkedIn https://www.linkedin.com/company/avenue-therapeutics/
Related People
Lucy LuFounder
United States -
New York City Metropolitan Area
I am an executive of a development-stage biotech company. Prior to working in the biotech industry, I was a senior equity analyst covering small- to mid-cap biotechnology companies. My expertise includes strategic planning, clinical development, regulatory strategy, business development, biotech equity valuation, investor relations and capital markets.
Maritime Fusion | $4,500,000 | (Nov 25, 2025)
Opti | $20,000,000 | (Nov 25, 2025)
Cordance Medical | $8,000,000 | (Nov 25, 2025)
AI One | $7,000,000 | (Nov 25, 2025)
Redrob | $10,000,000 | (Nov 25, 2025)
Pibit.AI | $7,000,000 | (Nov 25, 2025)
Votre | $3,750,000 | (Nov 25, 2025)
Tidalwave | $22,000,000 | (Nov 25, 2025)
Relixir | $2,000,000 | (Nov 25, 2025)
Interface | $3,500,000 | (Nov 25, 2025)
Model ML | $75,000,000 | (Nov 25, 2025)
Mirantus Health | $6,338,062 | (Nov 25, 2025)